Photometics is developing a cancer treatment using infrared light to perform "Selective Photo-Apoptosis" which triggers programmed cell death in cancer cells. Currently in Phase 1 trials, Photometics is initially targeting basal cell carcinoma, the world's most common cancer.
View Top Employees from Photometics, Inc.| Website | http://www.photometics.com |
| Revenue | $1 million |
| Employees | 2 (0 on RocketReach) |
| Founded | 2009 |
| Address | 600 1st Ave Ste 442, Seattle, Washington 98104, US |
| Phone | (530) 343-0906 |
| Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Business Services General, Health Care, Business Services, Medical Device, Therapeutics |
| Competitors | CivaTech Oncology, Inc., International Biomedical Devices Inc, Nanospectra Biosciences, Inc., Pyrexar Medical, Quantum Medical Imaging |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Photometics, Inc. employee's phone or email?
Photometics, Inc. Questions
The Photometics, Inc. annual revenue was $1 million in 2024.
Photometics, Inc. is based in Seattle, Washington.
The NAICS codes for Photometics, Inc. are [5417, 54, 541].
The SIC codes for Photometics, Inc. are [87, 873].
Related Companies
